Renato R. Fanin
Renato R. Fanin publishes mostly in Hematology, Genetics and Oncology, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Hematopoietic Stem Cell Transplantation.
- World rank
- #3,702,501 of 7,710,434 ranked researchers
- Rank in Italy
- #125,541 of 242,206
- Works
- 82
- Citations
- 1.7k
- Citations per work
- 20.2
What does Renato R. Fanin research?
Renato R. Fanin's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5162.3%
- Medicine5162.3%
- Everything else2732.5%
- Life Sciences45.2%
- 1Hematology24% of their works
- 2Genetics17% of their works
- 3Oncology8% of their works
- 4Pathology and Forensic Medicine7% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Molecular Biology5% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Which keywords describe Renato R. Fanin's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Hematopoietic Stem Cells, Minimal Residual Disease, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- International Myeloma Working Group
- Acute Myeloid Leukemia
- Lymphoma
- Childhood Cancer
- Myelofibrosis
- Graft-versus-Host Disease
- Genomic Aberrations
- Imatinib
- Minimal Residual Disease
- Rituximab
- Prognostic Factors
- Hematopoietic Stem Cells
- BCR-ABL
- Chronic Lymphocytic Leukemia
- Bone Marrow Niche
- JAK2 Mutation
- Acute Lymphoblastic Leukemia
- Classification
- AML
- Diagnosis Criteria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Prognostic Factors413 topics
- Rituximab322 topics
- Hematopoietic Stem Cells262 topics
- Minimal Residual Disease222 topics
- BCR-ABL191 topic
- Imatinib191 topic
- Chronic Lymphocytic Leukemia181 topic
- Genomic Aberrations181 topic
- Bone Marrow Niche171 topic
- Graft-versus-Host Disease171 topic
- JAK2 Mutation151 topic
- Myelofibrosis151 topic
- Acute Lymphoblastic Leukemia141 topic
- Childhood Cancer141 topic
- Classification141 topic
- Lymphoma141 topic
- AML91 topic
- Acute Myeloid Leukemia91 topic
- Diagnosis Criteria81 topic
- International Myeloma Working Group81 topic
Where does Renato R. Fanin work?
Renato R. Fanin's main affiliation in the publication record is Ospedale Santa Maria della Misericordia di Udine, Italy.
How many publications and citations does Renato R. Fanin have?
OpenAlex counts 82 works and 1,659 citations for Renato R. Fanin, an h-index of 22, ranking #3,702,501 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Renato R. Fanin. Posts are plain text and can be reported.